EBS vs. PLTK
EBS (Emergent BioSolutions Inc.) and PLTK (Playtika Holding Corp.) are both stocks. EBS operates in Drug Manufacturers - Specialty & Generic (Healthcare), while PLTK operates in Electronic Gaming & Multimedia (Communication Services). Over the past 5 years, EBS returned -33.43%/yr vs -29.17%/yr for PLTK. At a 0.27 correlation, their price movements are largely independent.
Performance
EBS vs. PLTK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EBS achieves a -36.49% return, which is significantly lower than PLTK's -9.87% return.
EBS
- 1D
- -1.88%
- 1M
- -7.10%
- YTD
- -36.49%
- 6M
- -38.72%
- 1Y
- 26.21%
- 3Y*
- -5.56%
- 5Y*
- -33.43%
- 10Y*
- -11.85%
PLTK
- 1D
- 2.01%
- 1M
- 4.09%
- YTD
- -9.87%
- 6M
- -11.20%
- 1Y
- -14.99%
- 3Y*
- -29.22%
- 5Y*
- -29.17%
- 10Y*
- —
EBS vs. PLTK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
EBS Emergent BioSolutions Inc. | -36.49% | 29.29% | 298.33% | -79.68% | -72.83% | -58.99% |
PLTK Playtika Holding Corp. | -9.87% | -37.16% | -16.05% | 2.47% | -50.78% | -48.23% |
Correlation
The correlation between EBS and PLTK is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jan 15, 2021 | 0.27 |
Fundamentals
EBS:
-$0.37
PLTK:
-$0.79
EBS:
0.49
PLTK:
0.48
EBS:
$676.80M
PLTK:
$2.79B
EBS:
$292.40M
PLTK:
$2.04B
EBS:
$126.60M
PLTK:
$144.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EBS vs. PLTK — Risk / Return Rank
EBS
PLTK
EBS vs. PLTK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and Playtika Holding Corp. (PLTK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EBS | PLTK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.61 | ||
| Sortino ratioReturn per unit of downside risk | +1.24 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.99 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.59 | -0.35 | +0.95 |
| Martin ratioReturn relative to average drawdown | 1.06 | -0.60 | +1.65 |
Loading charts...
Drawdowns
EBS vs. PLTK - Drawdown Comparison
The maximum EBS drawdown since its inception was -98.89%, which is greater than PLTK's maximum drawdown of -90.76%. Use the drawdown chart below to compare losses from any high point for EBS and PLTK.
Loading charts...
Drawdown Indicators
| EBS | PLTK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.89% | -90.76% | -8.13% |
Max Drawdown (1Y)Largest decline over 1 year | -44.24% | -42.58% | -1.66% |
Max Drawdown (3Y)Largest decline over 3 years | -83.91% | -75.12% | -8.79% |
Max Drawdown (5Y)Largest decline over 5 years | -97.73% | -89.33% | -8.40% |
Max Drawdown (10Y)Largest decline over 10 years | -98.89% | — | — |
Current DrawdownCurrent decline from peak | -94.18% | -87.91% | -6.27% |
Average DrawdownAverage peak-to-trough decline | -41.23% | -66.07% | +24.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.81% | 25.24% | -0.43% |
Volatility
EBS vs. PLTK - Volatility Comparison
Emergent BioSolutions Inc. (EBS) has a higher volatility of 17.79% compared to Playtika Holding Corp. (PLTK) at 15.37%. This indicates that EBS's price experiences larger fluctuations and is considered to be riskier than PLTK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EBS | PLTK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.79% | 15.37% | +2.42% |
Volatility (6M)Calculated over the trailing 6-month period | 48.07% | 39.62% | +8.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 82.47% | 51.30% | +31.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.28% | 50.86% | +51.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.78% | 50.09% | +29.69% |
Dividends
EBS vs. PLTK - Dividend Comparison
EBS has not paid dividends to shareholders, while PLTK's dividend yield for the trailing twelve months is around 8.43%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
EBS Emergent BioSolutions Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.65% |
PLTK Playtika Holding Corp. | 8.43% | 10.13% | 5.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
EBS vs. PLTK - Financials Comparison
This section allows you to compare key financial metrics between Emergent BioSolutions Inc. and Playtika Holding Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EBS vs. PLTK - Profitability Comparison
EBS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported a gross profit of 61.20M and revenue of 156.10M. Therefore, the gross margin over that period was 39.2%.
PLTK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Playtika Holding Corp. reported a gross profit of 552.50M and revenue of 744.70M. Therefore, the gross margin over that period was 74.2%.
EBS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported an operating income of 0.00 and revenue of 156.10M, resulting in an operating margin of 0.0%.
PLTK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Playtika Holding Corp. reported an operating income of -49.60M and revenue of 744.70M, resulting in an operating margin of -6.7%.
EBS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported a net income of 0.00 and revenue of 156.10M, resulting in a net margin of 0.0%.
PLTK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Playtika Holding Corp. reported a net income of -57.50M and revenue of 744.70M, resulting in a net margin of -7.7%.
Frequently Asked Questions
EBS and PLTK have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EBS has higher volatility (17.79%) compared to PLTK (15.37%). In terms of maximum drawdown, EBS dropped -98.89% vs PLTK's -90.76%.
EBS currently has the higher Sharpe Ratio (0.32 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EBS and PLTK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer